Published in Osteoporos Int on December 19, 2008
Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA. Osteoporos Int (2009) 1.12
Validation of a case definition for osteoporosis disease surveillance. Osteoporos Int (2010) 0.88
Association of gastrointestinal events and osteoporosis treatment initiation in newly diagnosed osteoporotic Israeli women. Int J Clin Pract (2015) 0.80
Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage. Clin Interv Aging (2015) 0.78
Hip fracture and other predictors of anti-osteoporosis drug use in Norway. Osteoporos Int (2012) 0.77
The impact of two educational interventions on osteoporosis diagnosis and treatment after fragility fracture: a population-based randomized controlled trial. Osteoporos Int (2011) 0.75
Predictors of Ibandronate Efficacy for the Management of Osteoporosis: A Meta-Regression Analysis. PLoS One (2016) 0.75
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser (1994) 17.37
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ (2002) 9.89
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
Predictive value of BMD for hip and other fractures. J Bone Miner Res (2005) 6.46
Assessment of fracture risk. Osteoporos Int (2004) 5.15
BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res (2003) 4.64
Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab (2000) 3.68
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int (2008) 3.44
An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int (2001) 2.94
The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2006) 2.24
Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J (2005) 2.15
Construction and validation of a population-based bone densitometry database. J Clin Densitom (2005) 1.24
Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom (2003) 1.00
Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence. J Bone Miner Res (2004) 1.00
Contribution of clinical risk factors to bone density-based absolute fracture risk assessment in postmenopausal women. Osteoporos Int (2003) 0.99
Absolute fracture risk reporting in clinical practice: a physician-centered survey. Osteoporos Int (2008) 0.96
Effects of risedronate on fracture risk in postmenopausal women with osteopenia. Osteoporos Int (2007) 0.91
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporos Int (2012) 1.76
Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study. Osteoporos Int (2013) 1.46
Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int (2010) 1.46
The burden of illness of osteoporosis in Canada. Osteoporos Int (2012) 1.34
Risk factors for low bone mass in healthy 40-60 year old women: a systematic review of the literature. Osteoporos Int (2008) 1.30
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (2010) 1.24
Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporos Int (2008) 1.15
Infliximab in Crohn's disease: first anniversary clinical experience. Am J Gastroenterol (2000) 1.14
Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int (2008) 1.11
Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort. Osteoporos Int (2009) 1.03
Comparison between various fracture risk assessment tools. Osteoporos Int (2014) 1.00
Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008). J Clin Endocrinol Metab (2012) 0.95
Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis. Osteoporos Int (2012) 0.93
Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS). Osteoporos Int (2014) 0.92
Review article: Osteoporosis and inflammatory bowel disease. Aliment Pharmacol Ther (2004) 0.92
The effect of socioeconomic status on bone density testing in a public health-care system. Osteoporos Int (2006) 0.90
Institutionalization following incident non-traumatic fractures in community-dwelling men and women. Osteoporos Int (2011) 0.90
High bone mineral density is associated with high body mass index. Osteoporos Int (2008) 0.89
Effects of anti-resorptive agents on trabecular bone score (TBS) in older women. Osteoporos Int (2012) 0.86
Ankle fractures do not predict osteoporotic fractures in women with or without diabetes. Osteoporos Int (2011) 0.86
Temporal trends in the incidence of osteoporotic fractures. Curr Osteoporos Rep (2013) 0.85
Cyclical etidronate: its effect on bone density in patients with acute spinal cord injury. Arch Phys Med Rehabil (1997) 0.85
Estimation of the lifetime risk of hip fracture for women and men in Canada. Osteoporos Int (2011) 0.83
FRAX provides robust fracture prediction regardless of socioeconomic status. Osteoporos Int (2013) 0.81
A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy. Curr Oncol (2011) 0.79
Thyroid scintigraphy and perchlorate discharge test in the diagnosis of congenital hypothyroidism. Eur J Nucl Med (1996) 0.78
Technetium-99m-IgG polyclonal human immunoglobulin scintigraphy in the evaluation of sacroiliitis. Eur J Nucl Med (1996) 0.78
A preliminary dual-energy X-ray absorptiometry-based finite element model for assessing osteoporotic hip fracture risk. Proc Inst Mech Eng H (2011) 0.78
Clinical correlates of Tc-99m sestamibi lung uptake. J Nucl Cardiol (2001) 0.78
Is lower income associated with an increased likelihood of qualification for treatment for osteoporosis in Canadian women? Osteoporos Int (2013) 0.78
Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry. Osteoporos Int (2015) 0.77
Associations between adverse social position and bone mineral density in women aged 50 years or older: data from the Manitoba Bone Density Program. Osteoporos Int (2013) 0.77
Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers? Osteoporos Int (2009) 0.77
Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of international cohorts. Calcif Tissue Int (2014) 0.76
A brain single photon-emission computed tomography (SPECT) study of generalized social phobia. Biol Psychiatry (1996) 0.76
Sex- and age-specific associations between income and incident major osteoporotic fractures in Canadian men and women: a population-based analysis. Osteoporos Int (2014) 0.76
Blood flow of the middle cerebral artery with sleep-disordered breathing: correlation with obstructive hypopneas. Stroke (1999) 0.75
Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study. Can J Gastroenterol (2009) 0.75
Hepatobiliary clearance of intravenous Tc-99m pertechnetate. Clin Nucl Med (1995) 0.75
Optimal decision criterion for detecting change in bone mineral density during serial monitoring: a Bayesian approach. Osteoporos Int (2008) 0.75
Examining the impact of reimbursement on referral to bone density testing for older adults: 8 years of data from the Barwon Statistical Division, Australia. Arch Osteoporos (2013) 0.75